BREAKING: Johnson & Johnson’s #COVID19 vaccine trial of 60,000 has been suddenly paused due to a new unexplained illness. Study enrollment website also frozen while DSMB (data safety monitoring board) reviews. to be updated.
The Phase 3 trial for Johnson & Johnson's #Covid19 vaccine has been paused while researchers look into an unexpected illness that occurred in one of the participants, @matthewherper reports. J&J would release no information on what the illness was.
Vaccine trials are working! And by that I mean, due diligence is being done. Safety signals are being monitored.
To some, this will feel like crashing into a wall. But these pauses are routine and part of the process. Stop, investigate, start again.
🚨BREAKING: huge clinical trial of Johnson & Johnson’s #coronavirus vaccine has been paused with enrollment of new participants stopped due to an "unexplained illness" in a study participant.
No details yet on the nature of the potential adverse reaction.
A pause. Not unexpected but still frustrating. Not even clear yet whether the single adverse event is in treatment or control group. This is why it's good to have multiple shots on goal.
@MattHerper report: J&J Covid-19 vaccine study paused due to illness. Nature of the illness is not yet public. This is a 60,000 patient study started 9/23/20. The AstraZeneca/Oxford vaccine trial remains paused in the US.
J&J's #Covid19 #vaccine study paused due to unexplained illness in participant - A document sent to outside researchers running the 60,000-patient trial states that a “pausing rule” has been met, & online enrollment has been closed... statnews.com/2020/10/12/joh… via @statnews
It’s reassuring that trials continue to be done with care> Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant statnews.com/2020/10/12/joh… via @statnews
11.
- Johnson & Johnson, who started their phase 3 clinical trial on 9/23/20, paused earlier this month and was also cleared by the FDA to restart on Friday, 10/23/20.
Archive: web.archive.org/web/2020101301…statnews.com/2020/10/12/joh…